Biotie Therapies Corp - Company & Market Research Reports

Biotie is a biopharmaceutical company focused on products for neurodegenerative and psychiatric disorders. Its best known product to-date is Selincro for alcohol dependence, which received European marketing authorization in 2013. It currently has a number of products in development, including tozadenant for Parkinson's disease and two compounds for cognitive disorders. Biotie Therapies Corp. is headquartered in Turku, Finland. As of April 18, 2016, it operates as a subsidiary of Acorda Therapeutics, Inc.

From
From
From
From
From
From
From
From
From
From
From
Inflammation - Pipeline Review, H1 2014 - Product Thumbnail Image

Inflammation - Pipeline Review, H1 2014

  • Drug Pipelines
  • 1103 Pages
From
From
From
Loading Indicator
adroll